Xiangbing Wang, MD, PhD

Xiangbing Wang, MD., Ph.D. is a Professor in the Division of Endocrinology at Rutgers, Robert Wood Johnson Medical School. He graduated from Hunan Medical University and received his Medical degree in 1983 and his MS degree in 1986. He obtained his Ph.D. in the fields of Physiology/Pharmacology from Oregon Health Science University in 1994 and finished his postgraduate training in the field of Endocrine Pharmacology at Yale University in 1996. He completed his 5-year clinical training in Internal Medicine and Endocrinology at Interfaith Medical Center, SUNY in 2001. For the last 15 years, he has run a clinical biochemical research laboratory and his clinical research has focused on vitamin D-vitamin D binding protein, primary hyperparathyroidism, parathyroid hormone, and cardiovascular risk factors. 

He is an experienced clinical endocrinologist, a principle investigator of several clinical trials and a Top Doctor of New Jersey 2017. Areas of clinical interest include thyroid disorders, primary hyperparathyroidism, and vitamin D related disorders. He is a member of the publication and clinical research committees of the American Association of Clinical Endocrinologists. He serves on the editorial boards of several peer-reviewed journals, including Endocrine Practice. He has published more than 100 research articles and more than 100 abstracts presented at national and international meetings. 

Publications: 

J Zaidan, X Wang, High-Dose Vitamin D3 for Critically Ill Vitamin D–Deficient Patients. N Engl J Med 2020; 382:1669-1671DOI: 10.1056/NEJMc2000993,2020 

J Zaidan, X Wang. Letter to the Editor: NORMOCALCEMIC HYPERPARATHYROIDISM: STUDY OF ITS PREVALENCE AND NATURAL HISTORY. J Clin Endocrinol Metab 105: Issue 7, dgaa275, https://doi.org/10.1210/clinem/dgaa275, 2020 

Meng L, Su C, Shapses SA, Al-Dayyeni A, He Y, Wang X. Lower total 25-hydroxyvitamin D but no difference in calculated or measured free 25-hydroxyvitamin D serum levels in patients with primary hyperparathyroidism. J Steroid Biochem Mol Biol. 2020 Feb 3;199:105616. doi: 10.1016/j.jsbmb.2020.105616, 2020.  

X Wang, LQ Meng, C Su, S Trooskin, ZF Sheng, S Shapses.  25-hydroxyvitamin D and Vitamin D Binding Protein Levels in Patients with Primary Hyperparathyroidism Before and after parathyroidectomy Frontiers in Endocrinology, Section of Bone Research, March 2019, DOI: 10.3389/fendo.2019.0017, 2019 

X Wang, Sue A. Shapses and H Alhraishawi.  Free and bioavailable 25-hydroxyvitamin D Levels in Patients with Primary Hyperparathyroidism.  Endocr Pract. 23: 66-71, 2017 

N Jassil, A Sharma, D Bikle and X Wang: Vitamin D Binding Protein and 25-Hydroxyvitamin D Levels: Emerging Clinical Applications.  Endocr Pract. 23: 605-61,2017 

Liu L, Li X, Xiang Y, Huang G, Lin J, Yang L, Zhao Y, Yang Z, Hou C, Li Y, Liu J, Zhu D, Leslie RD, Wang X, Zhou Z. Is the latent autoimmune diabetes in adults with low-titer GAD antibodies real LADA? A Nation-wide, Multi-Center Prospective Study (LADA CHINA STUDY 3).  Diabetes Care. 38: 16-21,2015 

Y Zhao, …,X Wang and Z Zhou. Dipeptidyl peptidase 4 inhibitor Sitagliptin maintains β cell function in patients with recent-onset latent autoimmune diabetes in adults: one-year prospective study.  J Clin Endocrinol Metab. 99: E876-80,2014.   

Wang XB, Peesapati, SK, Renedo M, Moktan, S.  Hemoglobin A1c levels in Non-Diabetic Patients with end-stage renal disease (ESRD) receiving hemodialysis.  J. Endoc Invest. 27:733-735, 2004. 

Wang, XB., N Sato, Greer, M. A, and P Falardeau:  Pituitary PRL secretion induced by tetrathylammonium is inhibited by dopamine through D2 receptors. Mol Cell. Endocrinol.112: 153-157,1995. 

Wang, X., Inukai, T., Greer M.A. and S.E.: Rat PRL and TSH secretion are regulated differently by K+ channel blockers. Am J Physiol  266:E39-E43, 1994. 

Wang, X., Wu, H., Chao, C.: Effect of propranolol on calcium, phosphorus and magnesium metabolism in Graves’ disease. METABOLISM 41:552-555, 1992. 

Sato N., Wang X., Greer M.A. et al: Medium hyposmolarity stimulates prolactin secretion in GH4C1 cells by inducing an increase in cytosolic free calcium. ENDOCRINOLOGY. 127:957-964, 1990. 

Wang X., Sato N., Greer M.A. et al: Lidocaine inhibits dispersed anterior pituitary cell thyrotropin and prolactin secretion induced by thyrotropin-releasing hormone or high medium potassium.  NEUROENDOCRINOLOGY. 50:555-559, 1989. 

Liu L., Wang X., Wu H., et al: The level of plasma VIII:Ag level in patients with hyperthyroidism.  J CHIN INTER MED. 26:265,1987. (Chinese) 

Books: 

Bikle, D. D., Xie, Z., Wang, X., eds. (2020). Vitamin D Binding Protein, Total and Free Vitamin D Levels in Different Physiological and Pathophysiological Conditions. Lausanne: Frontiers Media SA. doi: 10.3389/978-2-88963-578-8 (e-book) 

X Wang, Z Xie, A Santora, S Shapses and Z Xie. Monograph of a Special Issue on “Vitamin D Binding Protein and Vitamin D Levels” Int J Endocrinol. June 2014.  Hindawi Publication Corporation